Please login to the form below

Not currently logged in
Email:
Password:

chronic pain

This page shows the latest chronic pain news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

The 16-week study in patients with osteoarthritis (OA) pain evaluated subcutaneous administration of tanezumab, one of a new class of nerve growth factor (NGF) inhibitor drugs. ... In addition to OA pain, the biologic is being evaluated for chronic low

Latest news

More from news
Approximately 2 fully matching, plus 89 partially matching documents found.

Latest Intelligence

  • Tools for the digital world Tools for the digital world

    HealthUnlocked (HU) is one such network, designed to provide patients with a space in which they can discuss symptoms, relief and ways of coping with day-to-day chronic pain.

  • Pursuing better outcomes for people with pain Pursuing better outcomes for people with pain

    Pain is a sensation that we have all experienced in one form or another, but chronic pain that limits what people can do each day is unfortunately a reality for millions ... for chronic pain conditions.”.

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression ... With one in five European adults affected by

  • Deal Watch January 2016 Deal Watch January 2016

    Focusing on development for chronic pain, Quartet will receive a $20m fee (representing the upfront and milestones) to cover development through to phase IIa. ... 150. MannKind/ Receptor Life Sciences. Licence, collaboration. Multiple inhaled therapeutic

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    At the moment, biologics are generally delivered by intravenous or subcutaneous injection, which is effective but not desirable for patients, particularly for chronic conditions. ... Cara Therapeutics has a chronic pain treatment based on a peptide that

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics